Skip to main content
Browse topics  Search all clinical trials

Clinical trials : gastrointestinal

Showing 1 -10 of 24 results
To assess the safety of immunosupression in patients with IBD who have a history of cancer.

Multiple locations
Long-term safety and efficacy monitoring of HUMIRA® for patients with moderately to severely active ulcerative colitis.

North Shore University Hospital | 600 Northern Boulevard | Great Neck | NY 11021
To provide open-label Etrolizumab and safety monitoring to patients previously enrolled in Etrolizumab phase III studies.

North Shore University Hospital | 600 Northern Boulevard | Great Neck | NY 11021
The purpose of this study is to evaluate the safety, technical feasibility, and initial effectiveness (i.e., weight loss and prolonged gastric empyting) of a endoscopic guided treatment for obesity - endoscopic pyloric suturing...

Multiple locations
This study will evalutate the Ileocecal Valve in Patients With and Without Irritable Bowel Syndrome (IBS).

Long Island Jewish Medical Center | 270-05 76th Avenue | New Hyde Park | NY 11040
This study will examine the mechanism of action of Stretta Therapy applied to the gastroesophageal junction high pressure zone to treat Gastroesophageal Reflux Disease (GERD).

Multiple locations
The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

North Shore University Hospital | 600 Northern Boulevard | Great Neck | NY 11021
This is a multicenter, Phase III, double-blind, placebo-controlled study evaluating the safety and efficacy of etrolizumab during induction and maintenance treatment of moderate to severely active Crohn’s disease (CD) in patients who are anti-tumor necrosis factor (TNF) naïve (TNF-naïve) and in patients who are refractory or intolerant of tumor necrosis factor inhibitors.

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075
Despite the severity of symptoms and associated distress among gastroparesis patients, there are currently no treatments for the symptoms of gastroparesis approved for chronic use...

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075
This is a phase 3, randomized, double-blind, placebo-controlled study to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.

Lenox Hill Hospital | 100 E 77th St | New York | NY 10075